Tesamorelin questions answered in plain words
Tesamorelin is a prescription drug with one approved HIV use. This page answers questions about results, risks, timing, and firm limits.
What tesamorelin may change in deep belly fat
The main 26-week Phase 3 study followed 412 adults with HIV-related fat buildup. It was a large, late test before approval. Tesamorelin 2 mg per day cut deep belly fat by 15.2%. Placebo raised it 5.0% [1]. A placebo was a look-alike shot without the drug. Large studies haven't tested ordinary belly fat. The result can't predict yours.
How long tesamorelin took to reduce fat
Studies measured deep belly fat over 26 weeks. The decrease was still present at 52 weeks with continued treatment [1][2]. In 2026, one review joined five studies with similar time spans [13]. Scans showed change over months. They didn't show a quick result within weeks.
Which belly fat tesamorelin changed
Research in adults with HIV recorded a decrease in deep belly fat [1]. Growth hormone rose first. Then a liver-made hormone called IGF-1 rose. Fat under the skin didn't clearly change. BMI also stayed steady [1]. BMI compares weight with height. The scans showed fat loss in one place, not broad weight loss.
What tesamorelin has not proved outside HIV
The main fat-loss studies enrolled adults with HIV [1][2]. They were taking HIV medicine. Only one small study followed 13 healthy men. Their IGF-1 blood test rose [4]. Fat loss wasn't measured in that study. No large study has tested fat loss in the wider public. Fat loss outside HIV remains unproved.
What happened after tesamorelin stopped
In the 52-week follow-up, deep belly fat came back after tesamorelin ended [2]. A Phase 3 study, which is a large late test, found the same reversal [6]. The scan result depended on continued treatment. After treatment ended, fat moved back toward its starting amount.
How much deep fat changed with tesamorelin
After 26 weeks, scans showed deep belly fat was 15.2% lower [1]. Across two Phase 3 studies, more people on the drug got below 140 centimeters squared. That is an area on one scan slice, not waist size. Researchers made a 95% range where the true answer may fall. Even the lowest end still favored the drug [10]. Everyone had HIV-related fat buildup. The result doesn't predict your body.
What kind of drug tesamorelin is
Tesamorelin is a peptide, meaning a tiny chain of protein pieces [1]. The chain copies one hormone message from the brain. That message reaches the small growth gland. An extra piece helps the drug last longer. The gland raises growth hormone. The liver then raises IGF-1, a hormone that helps cells grow. FDA approval covers only belly fat tied to HIV medicine [5].
How tesamorelin leads from gland to belly fat
Tesamorelin gives cells in the pea-sized growth gland one message [4]. The gland releases growth hormone. In response, the liver makes IGF-1. This liver-made hormone helps cells grow. Both hormones also help break down deep belly fat. FDA approval covers extra belly fat tied to HIV medicine [5]. The FDA has not approved other uses.
What happened to blood sugar with tesamorelin
Fasting blood sugar showed no clear change among 13 healthy men [4]. Their bodies still answered insulin, the hormone that controls blood sugar. Over 52 weeks, changes in the HIV study were too small to matter [2]. Growth hormone can disturb sugar control. The label calls for blood tests when a person already has high risk.
What tesamorelin changed in fatty liver
A study lasting several months followed adults with HIV on treatment. Both liver fat and deep belly fat fell [3]. The finding applies to fatty liver in that HIV group. The FDA hasn't approved tesamorelin for fatty liver outside HIV.
What liver-cell tests found with tesamorelin
In the HIV study, liver fat fell with deep belly fat [3]. Tests found changes in how liver cells made energy. Blood tests linked with inflammation also improved [3]. Researchers hadn't yet shown whether the cell changes lasted or prevented liver damage. That is what longer study of liver tissue still needed to answer.
How much support the tesamorelin liver finding has
One study followed 50 adults with HIV. Tesamorelin lowered their liver fat [3]. In 2026, a review joined five studies. That review also found an average drop in liver fat [13]. The proof applies to fatty liver in adults living with HIV. It doesn't settle treatment outside that group.
How quickly tesamorelin falls in the blood
Trusted sources say half the drug leaves within 26–38 minutes. The drug then causes one longer change: IGF-1 stays raised. This liver-made hormone is tied to growth. That longer effect fit the daily plan researchers studied [11]. The timing doesn't set a plan for you.
Why tesamorelin's effect outlasts the drug
Tesamorelin stays in blood only briefly. A study used one model to describe how fast the level fell. Its rate was near 1,060 liters each hour [11]. That is an imaginary amount of drug-free blood, not blood inside a person. The large rate means very fast removal. IGF-1 stays raised after tesamorelin falls. The drug doesn't need to remain in the blood [11].
What tesamorelin side effects are known
Federal drug papers give one main hormone warning. Tesamorelin raises growth hormone and IGF-1, which helps cells grow. High growth hormone may cause water gain or disturb blood sugar. The liver-made hormone is a concern with active cancer. Shot-site reactions also occurred, but this source gives no count or details. A federal review found no clear liver injury from tesamorelin [5]. Other harm is still possible.
Why tesamorelin may cause water gain
The FDA warning includes holding extra water. This can happen with drugs that raise growth hormone. The main studies focused on deep belly fat and blood sugar [1][2]. They didn't track water gain as a main result. That means these papers can't say how often it happened.
Who cannot receive tesamorelin under the label
Active cancer is one reason the FDA label bars tesamorelin. The drug raises IGF-1, a hormone that can help normal cells and cancer cells grow. The label also bars tesamorelin during pregnancy. A known allergy to the drug or its other ingredients is another reason. In animal studies, unborn young developed fluid around the brain [5]. Sport rules also ban the drug.
What tesamorelin has FDA approval to treat
Tesamorelin has one approved use. In 2010, tesamorelin gained United States approval for extra belly fat tied to HIV medicine [5]. Approval doesn't cover ordinary weight loss, aging, or fat loss without HIV. The FDA has not approved those uses.
How IGF-1 rises after tesamorelin
The studies show three parts.
- Tesamorelin raises a liver-made hormone that helps cells grow.
- Among 13 healthy men, that hormone rose 181 micrograms per liter [4]. One gram contains one million micrograms. The rise didn't prove benefit or harm.
- The largest HIV study also found a sharp rise [1].
The blood change followed the growth-hormone rise. Several studies found it with tesamorelin.
How tesamorelin starts a brief hormone burst
Tesamorelin gives growth-gland cells a copy of the brain's usual message [4]. The small gland sits beneath the brain. Its cells release growth hormone in bursts. One study tracked those bursts over time [11]. Growth hormone rose and fell. It didn't stay high all day.
What tesamorelin does instead of supplying growth hormone
Tesamorelin copies the brain's order to release growth hormone [11]. The drug isn't growth hormone itself. Your gland still makes and releases its own hormone in bursts. A ready-made growth hormone shot supplies the hormone directly.
How tesamorelin connects the gland with deep fat
Tesamorelin gives growth-gland cells one hormone message [4]. Those cells put growth hormone in your blood. In response, the liver makes IGF-1. This liver-made hormone helps cells grow. Together, the two hormones also help break down fat. Most of the measured change was in deep belly fat [4]. The research page gives the full order.